NASDAQ:VMD - Viemed Healthcare Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $11.50
  • Forecasted Upside: 119.89 %
  • Number of Analysts: 3
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 3 Buy Ratings
  • 0 Strong Buy Ratings
$5.23
▼ -0.17 (-3.15%)

This chart shows the closing price for VMD by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Viemed Healthcare Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for VMD and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for VMD

Analyst Price Target is $11.50
▲ +119.89% Upside Potential
This price target is based on 3 analysts offering 12 month price targets for Viemed Healthcare in the last 3 months. The average price target is $11.50, with a high forecast of $14.00 and a low forecast of $9.00. The average price target represents a 119.89% upside from the last price of $5.23.

This chart shows the closing price for VMD for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 3 polled investment analysts is to buy stock in Viemed Healthcare.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/4/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/2/2020
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/1/2020
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/1/2021
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/30/2021
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
8/28/2021
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/27/2021
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/26/2021

Latest Recommendations

  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/3/2021Royal Bank of CanadaLower Price TargetOutperform$13.00 ➝ $9.00High
9/17/2021Acumen CapitalReiterated RatingBuyC$14.00High
8/4/2021Bloom BurtonUpgradeAccumulate ➝ BuyLow
3/5/2021Royal Bank of CanadaInitiated CoverageOutperform$13.00Low
10/28/2020Acumen CapitalReiterated RatingBuy$12.00High
10/19/2020Bloom BurtonReiterated RatingAccumulateHigh
5/5/2020Beacon SecuritiesReiterated RatingBuyLow
8/12/2019Lake Street CapitalBoost Price Target$10.00 ➝ $12.00N/A
(Data available from 11/27/2016 forward)

News Sentiment Rating

0.24 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/1/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/31/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/30/2021
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
7/30/2021
  • 2 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
8/29/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
9/28/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/28/2021
  • 2 very positive mentions
  • 7 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
11/27/2021

Current Sentiment

  • 2 very positive mentions
  • 7 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Viemed Healthcare logo
Viemed Healthcare, Inc. engages in the provision of home healthcare solutions. Through its subsidiaries, it supplies home medical equipment which provides post-acute respiratory services. It also offers respiratory disease management and in-home sleep testing and sleep apnea treatment. The company was founded by Casey Hoyt, Max Hoyt, and Michael Moore on December 14, 2016 and is headquartered in Lafayette, LA.
Read More

Today's Range

Now: $5.23
Low: $5.05
High: $5.28

50 Day Range

MA: $5.69
Low: $5.23
High: $6.08

52 Week Range

Now: $5.23
Low: $5.05
High: $10.96

Volume

130,508 shs

Average Volume

176,139 shs

Market Capitalization

$208.00 million

P/E Ratio

21.79

Dividend Yield

N/A

Beta

1.48

Frequently Asked Questions

What sell-side analysts currently cover shares of Viemed Healthcare?

The following sell-side analysts have issued stock ratings on Viemed Healthcare in the last year: Acumen Capital, Bloom Burton, Royal Bank of Canada, TheStreet, and Zacks Investment Research.
View the latest analyst ratings for VMD.

What is the current price target for Viemed Healthcare?

2 Wall Street analysts have set twelve-month price targets for Viemed Healthcare in the last year. Their average twelve-month price target is $11.50, suggesting a possible upside of 119.9%. Acumen Capital has the highest price target set, predicting VMD will reach $14.00 in the next twelve months. Royal Bank of Canada has the lowest price target set, forecasting a price of $9.00 for Viemed Healthcare in the next year.
View the latest price targets for VMD.

What is the current consensus analyst rating for Viemed Healthcare?

Viemed Healthcare currently has 3 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe VMD will outperform the market and that investors should add to their positions of Viemed Healthcare.
View the latest ratings for VMD.

How do I contact Viemed Healthcare's investor relations team?

Viemed Healthcare's physical mailing address is 625 East Kaliste Saloom Road, Lafayette LA, 70508. The company's listed phone number is (337) 504-3802 and its investor relations email address is [email protected] The official website for Viemed Healthcare is www.viemed.com.